Devices › Device types
FDA product code MLV · class 3 · Unknown
Transcatheter septal occluder: medical device reports filed with FDA
6,948 reports carry this product code, 1999–2026; 12 brands with a page.
- 6,948
- reports with this product code
- 0% of all MAUDE reports
- 854
- reports, 12 months to August 2026
- 801 in the 12 months before
- 37.8%
- classified as malfunction
- 62.3% across all reports
- 2.8%
- classified as death, as reported
- 0.9% across all reports
Product code MLV is FDA's classification for "Transcatheter septal occluder" (unknown panel), a class 3 device. 6,948 medical device reports carry this product code, 0% of the MAUDE database, from October 1999 to August 2026.
854 reports arrived in the 12 months to August 2026, close to the 801 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (58.1%), malfunction (37.8%) and death (2.8%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Amplatzer Septal Occluder | 3,490 | 406 | 2.4% | 43.4% |
| Amplatzer PFO Occluder | 596 | 42 | 2.8% | 45.7% |
| GORE CARDIOFORM Septal Occluder | 535 | 80 | 1.3% | 6.2% |
| Amplatzer Talisman PFO Occluder | 426 | 125 | 0.9% | 67.8% |
| Gore Helex Septal Occluder | 279 | 0 | 0.4% | 5.4% |
| Amplatzer Cribriform Occluder | 278 | 0 | 0.4% | 37.3% |
| GORE CARDIOFORM ASD Occluder | 274 | 57 | 0.7% | 4.4% |
| Amplatzer Multi-Fenestrated Septal Occluder - Cribriform | 255 | 63 | 0.4% | 82% |
| Amplatzer Muscular VSD Occluder | 242 | 44 | 9.1% | 24.4% |
| Amplatzer Duct Occluder | 17 | 83 | 2.1% | 40.4% |
| Amplatzer Torqvue Delivery System | 2 | 29 | 7.2% | 42.8% |
| GORE DrySeal Flex Introducer Sheath | 1 | 283 | 5.3% | 8.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Abbott Medical | 3,184 | 45.8% |
| Aga Medical | 2,388 | 34.4% |
| W L Gore & Associates | 1,093 | 15.7% |
| St Jude Medical Costa Rica Ltda | 6 | 0.1% |
| Medtronic Vascular | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Difficult to fold, unfold or collapse | 1,841 | 26.5% |
| Migration or expulsion of device | 1,005 | 14.5% |
| Material deformation | 823 | 11.8% |
| Patient device interaction problem | 346 | 5% |
| Explanted | 279 | 4% |
| Insufficient device problem information | 263 | 3.8% |
| Patient-device incompatibilitythe device did not suit the patient | 192 | 2.8% |
| Device dislodged or dislocated | 180 | 2.6% |
| Off-label use | 167 | 2.4% |
| Unintended movement | 161 | 2.3% |
| Inadequacy of device shape and/or size | 158 | 2.3% |
| Migrationthe device moved from where it was placed | 128 | 1.8% |
| Difficult to removethe device was hard to remove | 114 | 1.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 107 | 1.5% |
| Device, removal of (non-implant) | 106 | 1.5% |
| Improper or incorrect procedure or method | 96 | 1.4% |
| Biocompatibility | 95 | 1.4% |
| Replace | 91 | 1.3% |
| Device remains implanted | 81 | 1.2% |
| Malposition of device | 79 | 1.1% |
Questions about transcatheter septal occluder reports
What is product code MLV?
FDA's classification code for "Transcatheter septal occluder", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
6,948 reports through August 2026, 854 of them in the latest 12 months.
Which brands appear most often?
Amplatzer Septal Occluder (3,490), Amplatzer PFO Occluder (596), GORE CARDIOFORM Septal Occluder (535), Amplatzer Talisman PFO Occluder (426) and Gore Helex Septal Occluder (279). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.